Vanita Noronha - Concepedia

Author

Vanita Noronha

Also Known As

A Joshi, A Ramaswamy, Amit Joshi, Anant Ramaswamy, JayitaKedar Deodhar, Kumar Prabhash, MV Krishna, Mansi Sharma, Noronha, V., Noronha, Vanita

648

Publications

7.2K

Citations

H-Index

100

Concepts

All Affiliations

Tata Memorial Hospital Homi Bhabha National Institute Advanced Centre for Treatment, Research and Education in Cancer Malabar Cancer Centre

About

Vanita Noronha is an author at Tata Memorial Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	41	1.4K
2	Health Sciences	11	13	354
3	Public Health	5	5	126
4	Nursing	3	3	61
5	Arts	1	1	12

Vanita Noronha

110

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer Vanita Noronha, Vijay Patil, Amit Joshi, Journal of Clinical Oncology	2019	415
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial Vanita Noronha, Amit Joshi, Vijay Patil, Journal of Clinical Oncology	2017	326
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial Vedang Murthy, Priyamvada Maitre, Sadhana Kannan, Journal of Clinical Oncology	2021	308
Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience Kumar Prabhash, Vanita Noronha, Rajesh Dikshit, Indian Journal of Cancer	2012	183
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study Vijay Patil, Vanita Noronha, Nandini Menon, Journal of Clinical Oncology	2022	181
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers Vijay Patil, Kumar Prabhash, Vanita Noronha, Oral Oncology Surgical OncologyMedicineOral CavitySurgeryCancer Treatment	2014	160
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations Kanika Bajaj Pahuja, Thong Tien Nguyen, Bijay S. Jaiswal, Cancer Cell Signal TransductionProtein TransportIntracellular TraffickingCellular BiochemistryJuxtamembrane Domain Mutations	2018	159
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer Vijay Patil, Vanita Noronha, Amit Joshi, Cancer	2019	127
Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity Anuradha Chougule, Kumar Prabhash, Vanita Noronha, PLoS ONE	2013	126
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial Vijay Patil, Vanita Noronha, Sachin Dhumal, The Lancet Global Health	2020	98

Page 1